Palisade Bio Inc. (PALI) Misses Q2 EPS by 332c

Palisade Bio Inc. (NASDAQ: PALI) reported Q2 EPS of ($3.32).

For earnings history and earnings-related data on Palisade Bio Inc. (PALI) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Tesla Nears Unveiling of Radical New ‘Flying’ Roadster - The Information
• Tapestry Inc. (TPR) PT Raised to $185 at Bernstein SocGen Group